James Leighton-Scott

Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: A retrospective cohort study

Arlene M. Gallagher, James Leighton-Scott, Tjeerd van Staa · Clinical Therapeutics · 2009 · 37 citations

Pharmacy, Family Medicine, Pharmacotherapy +14

Pharmacokinetics of recombinant human growth hormone administered by cool.click™ 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle

Chris Brearley, Anthony Priestley, James Leighton-Scott et al. · BMC Clinical Pharmacology · 2007 · 34 citations · Full text

Pharmacy, Endocrinology, Pharmacokinetics +15

The unique role of transdermal buprenorphine in the global chronic pain epidemic

Joseph V. Pergolizzi, Willem Scholten, Kevin J. Smith et al. · Acta anaesthesiologica Taiwanica · 2015 · 28 citations

Nursing, Pharmacology, Pharmacotherapy +16

Prevalence and Incidence Trends for Diagnosed Prescription Opioid Use Disorders in the United Kingdom

Andrew Cooper, Jenna C. Willis, Janice L. Fuller et al. · Pain and Therapy · 2017 · 28 citations · Full text

Medicine, Pharmacology, Clinical Epidemiology +12